September 13, 2018 / 10:31 AM / 2 months ago

Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT, Sept 13 (Reuters) - The head of Bayer’s pharmaceuticals division Dieter Weinand will quit to joint Sanofi to head the French drugmaker’s new Primary Care unit.

In a statement on Thursday, Germany’s Bayer said Weinand would be succeeded by Stefan Oelrich, currently a member of Sanofi’s executive committee in charge of the global diabetes and cardiovascular business.

Bayer added that Hartmut Klusik, its labour director and board member responsible for technology, was given a contract extension by one year until the end of 2019, confirming a Reuters report.

Liam Condon, who was recently picked to lead Bayer’s enlarged Crop Science unit and oversee the integration of seeds maker Monsanto, would get a fresh five-year contract, Bayer added.

Reporting by Ludwig Burger; editing by Thomas Seythal

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below